Sažetak sa skupa
https://doi.org/10.33004/reumatizam-supp-73-1-29
Changing the management of systemic vasculitis: the era of targeted therapies
Roberto Padoan
*
* Dopisni autor.
Puni tekst: engleski pdf 1.030 Kb
str. 34-34
preuzimanja: 0
citiraj
APA 6th Edition
Padoan, R. (2026). Changing the management of systemic vasculitis: the era of targeted therapies. Reumatizam, 73 (Supp 1), 34-34. https://doi.org/10.33004/reumatizam-supp-73-1-29
MLA 8th Edition
Padoan, Roberto. "Changing the management of systemic vasculitis: the era of targeted therapies." Reumatizam, vol. 73, br. Supp 1, 2026, str. 34-34. https://doi.org/10.33004/reumatizam-supp-73-1-29. Citirano 04.11.2026.
Chicago 17th Edition
Padoan, Roberto. "Changing the management of systemic vasculitis: the era of targeted therapies." Reumatizam 73, br. Supp 1 (2026): 34-34. https://doi.org/10.33004/reumatizam-supp-73-1-29
Harvard
Padoan, R. (2026). 'Changing the management of systemic vasculitis: the era of targeted therapies', Reumatizam, 73(Supp 1), str. 34-34. https://doi.org/10.33004/reumatizam-supp-73-1-29
Vancouver
Padoan R. Changing the management of systemic vasculitis: the era of targeted therapies. Reumatizam [Internet]. 2026 [pristupljeno 04.11.2026.];73(Supp 1):34-34. https://doi.org/10.33004/reumatizam-supp-73-1-29
IEEE
R. Padoan, "Changing the management of systemic vasculitis: the era of targeted therapies", Reumatizam, vol.73, br. Supp 1, str. 34-34, 2026. [Online]. https://doi.org/10.33004/reumatizam-supp-73-1-29
Sažetak
Ključne riječi
systemic vasculitis, targeted therapies, biologic therapy, ANCA-associated vasculitis, giant cell arteritis
Hrčak ID:
352812
URI
https://hrcak.srce.hr/352812
Datum izdavanja:
21.10.2026.
Podaci na drugim jezicima:
hrvatski
Posjeta: 0
*